Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials
Top Cited Papers
- 20 May 2005
- journal article
- research article
- Published by Elsevier BV in The Lancet
- Vol. 365 (9472), 1687-1717
- https://doi.org/10.1016/s0140-6736(05)66544-0
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Adjuvant Chemotherapy in Early Breast Cancer: Optimal and Suboptimal Anthracycline-Containing RegimensBreast Cancer Research and Treatment, 2003
- Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: an overview of the randomised trialsThe Lancet, 2000
- UK and USA breast cancer deaths down 25% in year 2000 at ages 20–69 yearsThe Lancet, 2000
- Polychemotherapy for early breast cancer: an overview of the randomised trialsThe Lancet, 1998
- Tamoxifen for early breast cancer: an overview of the randomised trialsThe Lancet, 1998
- Randomized Trial of Two Versus Five Years of Adjuvant Tamoxifen for Postmenopausal Early Stage Breast CancerJNCI Journal of the National Cancer Institute, 1996
- Ovarian ablation in early breast cancer: overview of the randomised trialsThe Lancet, 1996
- Effects of Radiotherapy and Surgery in Early Breast Cancer — An Overview of the Randomized TrialsThe New England Journal of Medicine, 1995
- Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy: 133 randomised trials involving 31 000 recurrences and 24 000 deaths among 75 000 womenThe Lancet, 1992
- Effects of Adjuvant Tamoxifen and of Cytotoxic Therapy on Mortality in Early Breast CancerThe New England Journal of Medicine, 1988